This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mehta AN, Emmett JB, Emmett M. GOLD MARK: an anion gap mnemonic for the 21st century. Lancet 2008;372(9642):892. doi:10.1016/S0140-6736(08)61398-7MehtaANEmmettJBEmmettM.GOLD MARK: an anion gap mnemonic for the 21st century. 2008;372(9642):892. DOI:10.1016/S0140-6736(08)61398-7Open DOISearch in Google Scholar
Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): A tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol 2014;9(1):191–200. doi:10.2215/CJN.07730713EmmettM.Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): A tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. 2014;9(1):191–200. DOI:10.2215/CJN.07730713Open DOISearch in Google Scholar
Creer MH, Lau BWC, Jones JD, Chan KM. Pyroglutamic acidemia in an adult patient. Clin Chem 1989;35(4):684–6. doi:10.1093/clinchem/35.4.684CreerMHLauBWCJonesJDChanKM.Pyroglutamic acidemia in an adult patient. 1989;35(4):684–6. DOI:10.1093/clinchem/35.4.684Open DOISearch in Google Scholar
Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: Clinical and biochemical findings in eleven subjects. Clin Chem 1998;44(7):1497–1503. doi:10.1093/clinchem/44.7.1497PittJJHauserS.Transient 5-oxoprolinuria and high anion gap metabolic acidosis: Clinical and biochemical findings in eleven subjects. 1998;44(7):1497–1503. DOI:10.1093/clinchem/44.7.1497Open DOISearch in Google Scholar
Liss DB, Paden MS, Schwarz ES, Mullins ME. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure? Clin Toxicol 2013;51(9):817–27. doi:10.3109/15563650.2013.844822LissDBPadenMSSchwarzESMullinsME.What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?2013;51(9):817–27. DOI:10.3109/15563650.2013.844822Open DOISearch in Google Scholar
Croal BL, Glen ACA, Kelly CJG, Logan RW. Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clin Chem 1998;44(2):336–340. doi:10.1093/clinchem/44.2.336CroalBLGlenACAKellyCJGLoganRW.Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. 1998;44(2):336–340. DOI:10.1093/clinchem/44.2.336Open DOISearch in Google Scholar
Bonham JR, Rattenbury JM, Meeks A, Pollitt RJ. Pyroglutamicaciduria from vigabatrin. Lancet 1989;1(8652):1452–3. doi:10.1016/S0140-6736(89)90158-XBonhamJRRattenburyJMMeeksAPollittRJ.Pyroglutamicaciduria from vigabatrin. 1989;1(8652):1452–3. DOI:10.1016/S0140-6736(89)90158-XOpen DOISearch in Google Scholar
Fenves AZ, Kirkpatrick HM, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 2006;1(3):441–7. doi:10.2215/CJN.01411005FenvesAZKirkpatrickHMPatelVVSweetmanLEmmettM.Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. 2006;1(3):441–7. DOI:10.2215/CJN.01411005Open DOISearch in Google Scholar
O’Brien LMN, Hooper M, Flemmer M, Marik PE. Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: An under diagnosed phenomenon. BMJ Case Rep [Internet] 2012:1–3. doi:10.1136/bcr.bcr.03.2012.6020O’BrienLMNHooperMFlemmerMMarikPE.Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: An under diagnosed phenomenon. [Internet] 2012:1–3. DOI:10.1136/bcr.bcr.03.2012.6020Open DOISearch in Google Scholar
Tummers S, Oei SDX, Nooteboom F, Meenks SD, Wilting RM. Severe metabolic acidosis induced by 5-oxoproline accumulation after paracetamol and flucloxacillin administration. Neth J Crit Care 2020;28.TummersSOeiSDXNooteboomFMeenksSDWiltingRM.Severe metabolic acidosis induced by 5-oxoproline accumulation after paracetamol and flucloxacillin administration. 2020;28.Search in Google Scholar
Wu SL, Wei TY, Lin SW, Su KY, Kuo CH. Metabolomics Investigation of voriconazole-induced hepatotoxicity in mice. Chem Res Toxicol 2019;32(9):1840–9. doi:10.1021/acs.chemrestox.9b00176WuSLWeiTYLinSWSuKYKuoCH.Metabolomics Investigation of voriconazole-induced hepatotoxicity in mice. 2019;32(9):1840–9. DOI:10.1021/acs.chemrestox.9b00176Open DOISearch in Google Scholar
Hoshitsuki K, Molinelli AR, Inaba H, Rubnitz JE, Barker PJ. Metabolic Acidosis in a pediatric patient with leukemia and fungal infection. Clin Chem 2020;66(4):518–22. doi:10.1093/CLINCHEM/HVZ035HoshitsukiKMolinelliARInabaHRubnitzJEBarkerPJ.Metabolic Acidosis in a pediatric patient with leukemia and fungal infection. 2020;66(4):518–22. DOI:10.1093/CLINCHEM/HVZ035Open DOISearch in Google Scholar
Mårtensson J, Gustafsson J, Larsson A. A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria). J Inherit Metab Dis 1989;12(2):120–30. doi:10.1007/BF01800713MårtenssonJGustafssonJLarssonA.A therapeutic trial with N-acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5-oxoprolinuria). 1989;12(2):120–30. DOI:10.1007/BF01800713Open DOISearch in Google Scholar